Mega-Journal PLOS ONE Continues to Shrink
The world's largest scholarly journal, PLOS ONE, is seeing fewer and fewer researchers publish their work in it as the open-access publishing market evolves.
Send us a link
The world's largest scholarly journal, PLOS ONE, is seeing fewer and fewer researchers publish their work in it as the open-access publishing market evolves.
Highly productive researchers have significantly higher probability to produce top cited papers.
Articles with more narrative abstracts are cited more often.
Publication bias, in which positive results are preferentially reported by authors and published by journals, can restrict the visibility of evidence against false claims and allow such claims to be canonized inappropriately as facts.
Neuroskeptic« No Need To Worry About False Positives in fMRI?What Happens to Rejected Papers?By Neuroskeptic | January 3, 2017 2:43 pm32The pain of rejection is one that every scientist has felt: but what happens to papers after they’re declined by a journal?In a new study, researchers Earnshaw et al. traced the fate of almost 1,000 manuscripts which had been submitted to and rejected by ear, nose and throat journal Clinical Otolaryngology between 2011 to 2013.
Fake news and "post-truth," which may have played a role in the 2016 elections, are also problems in science publishing and science journalism.
Mr. Beall’s website, which identifies “predatory open access scholarly publishers” that masquerade as scholarly journals, has grown to 923 publishers from 18 in 2011.
Universal Green OA Is the Most Efficient and Fairest of Science Publishing Strategies.
10 simple rules to help you get across the main idea of your paper.
Researchers at top-flight institutions are not immune to charms of questionable journals
Prospective cohort study of unsolicited and unwanted academic invitations.
French, German, and UK's joint guidelines for high-quality publications in scientific journals.
A list of some of the shady things Elsevier has been previously caught doing
A little over 1 year ago, the American Society for Microbiology (ASM) launched mSphere as an open-access, online, pan-microbial sciences journal. We established two major goals: publish cutting-edge science and implement policies and processes to make the publication experience less onerous for authors.
The open-access microbiology journal mSphere will give authors a "super-fast track" option toward publication. The idea has some ardent fans, but is also drawing doubts.
How could an article with numerous shortcomings be published in top-tier journal Nature? Hester van Santen reveals how the gate-keepers of science knowingly let flawed research slip through.
A graph shows the dramatic rise of open access mega-journals such as Plos One, which offer to publish papers based on their scientific soundness rather than the significance or novelty of the results, and which accept research across a broad range of disciplines.
A few slides comparing ResearchGate, Academia, Mendeley and others.
More than 600 journals across Nature Research, Springer, BioMed Central and Palgrave Macmillan have committed to encouraging good practice in the sharing and archiving and citation of research data by adopting new Springer Nature research data policies.
A free and open tool for collaborative editing, instant publishing, continuous review, and grassroots journals. PubPub is supported and advised by many MIT Media Lab professors, students, and friends.
PeerJ offers the better technology and user experience than bioRxiv, but bioRxiv has greater adoption in the biodata sciences.
To claim credit for a discovery, we publish it in a peer-reviewed journal; to get a job in academia or money to run a lab, we present piles of these published papers to universities and funding agencies. Publishing is so embedded in the practice of science that whoever controls the journals controls access to the entire profession. It is, therefore, worth examining to whom we have entrusted the keys to the kingdom of science.
A market place for scientific and scholarly journals which publish articles in open access. Quality scoring of the journals in QOAM is based on academic crowd sourcing; price information includes institutional licensed pricing.
Consortium backed by US NIH is first major biology programme to mandate online publication of results ahead of peer review.
In an era of online discussion, debate must remain nuanced and courteous.
John Wiley & Sons Inc. announced today plans to require ORCID iDs as part of the manuscript submission process for a large number of journals. Beginning in winter 2016, more than 500 Wiley journals using ScholarOne Manuscripts will require the submitting author (only) to provide an ORCID identifier (iD) when submitting a manuscript. Wiley is proud to be the first major publisher to join other stakeholders that have signed ORCID’s open letter.
Every scientist wants his or her paper to appear in Cell, Nature or Science. In today’s scientific world, being associated with such publications is synonymous with prestige and excellence, opening doors to top positions and coveted awards.
While the total output of the eleven open-access mega-journals grew by 14.9% between 2014 and 2015, this growth is largely attributable to the increased output of Scientific Reports and Medicine.
The first articles have gone live on Wellcome Open Research; 15 of them in total, with more submissions in the pipeline.
Biologists in particular are writing their papers in a less formal style.